| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EZFL | Common Stock | Award | $0 | +128K | +42.59% | $0.00 | 428K | Jun 3, 2022 | Direct | F1, F2, F3 |
| Id | Content |
|---|---|
| F1 | The shares will fully vest in 12 months from the grant date or one day before the Issuer's 2023 annual meeting, whichever is sooner. Should the Reporting Person leave the Issuer's board of directors prior to vesting, the Reporting Person will be awarded a grant on a pro rata basis based on the time spent as a member of the board of directors. |
| F2 | The Reporting Person holds 186,010 shares of Common Stock through an entity Cameo Life Sciences Investments, LLC. |
| F3 | Granted pursuant to the Issuer's equity incentive plan. |